Gara Jalqabaatti › Ocular Hypertension
Qorannoo klinikaalii Ocular Hypertension Ameerikaa Keessatti hirmaatuu
Qorannoo 21 Ocular Hypertension f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
Naannoon
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
iDose TR Administration in an Office-Based Surgery Setting
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07816692REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07675824A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07661329Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07075718Clarifying the Optimal Application of SLT Therapy Trial
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT04967989Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT04401982Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular Hypertension
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Wax-2026 · NCT07588152Direct vs Standard SLT for Glaucoma: A Noninferiority Trial
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT0740815424-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Cam-2026 · NCT07325240DSLT for Reducing Medication in Glaucoma
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 20-Elb-2026 · NCT07390890Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Bit-2026 · NCT07495852Automated Applanation Tonometry - Updated
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Bit-2026 · NCT07298356Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Bit-2026 · NCT07217678Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Gur-2026 · NCT07400926Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 45 fi ol · Saalaa hunda · Haaromfame 21-Ama-2026 · NCT06848946Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Mud-2025 · NCT06629649Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 22 fi ol · Saalaa hunda · Haaromfame 20-Onk-2025 · NCT07218796Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 22 fi ol · Saalaa hunda · Haaromfame 20-Onk-2025 · NCT07218783A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2025 · NCT07076303Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2023 · NCT05844384Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2022 · NCT05401357Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.